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SYSTEMIC SCLEROSIS 
Fourteen cases treated with chelatiori (disodium EDTA) and/or pyridoxine, with comments on the 
possible role of altered tryptophan metabolism in pathogenesis. 
ROBERT E . BIRK, M.D.' ' AND CLARENCE E . RUPE, M.D. '^ '* 
DESPITE THE recent evidence suggesting a close immunoligical relationship', in dealing 
with any large number of patients with "collagen" diseases, the clinician soon becomes 
aware that systemic sclerosis does not share many of the characteristics of the other 
members of the group, and in particular does not respond well, if at all, to the 
common therapeutic measures useful in the others. This is particularly true in the 
lack of response to steroid therapy^; it appears, at least in some cases, that steroids 
actually are contraindicated, apparently causing further dissemination of the sclerosis. 
Systemic sclerosis alone, also, seems to primarily effect the collagenous connective 
tissue of the skin and other organs .^ 
In addition to the basic modalities of physiotherapy, protective measures for 
those patients exhibiting cold intolerance, and vasodilators, many therapeutic agents, 
in addition to steroid therapy, have been tried, and found to be fully or partially 
ineffective.^'^''''^ Para-amino-benzoic acid and its potassium salt, except in the hands 
of Zarafonetis and his group,'-'" have not proved to be the answer," but their role in 
increasing tissue oxygenation' should theoretically have some effect. The role of 
adenosine-5-monophosphoric acid is probably only that of a vasodilator.'^ 
Recent reports on the use of relaxin following estrogenic priming" have been 
encouraging, but not enough evidence is yet available for critical appraisal. Un-
fortunately, this hormone is potentially toxic and death has been reported with 
doses far below the effective requirements.'^ One further problem arises in the 
difficulty of withdrawing steroids from patients already being treated with these agents, 
a requirement due to the action of steroids in blocking the effects of relaxin." 
The use of chelation therapy in systemic sclerosis was first reported by Klein 
and Harris'* in 1955, although Boyle et al.'^ later reported a case treated by them 
in 1953. At that time, the rationale of therapy with this agent was in its ability to 
•"Medical Clinic No. 2. 
»* Medical Clinic No. 4. 
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bind and remove excessive calcium from the tissue." Boyle et al.'* reported one-third 
less calcium in a post-treatment skin biopsy. This effect has also been found to be 
useful in the treatment of the closely related conditions of calcinosis universalis," and 
interstitial calcinosis with Raynaud's phenomenon." These two conditions may well 
be forms of systemic sclerosis. Two cases of polymyositis reported by Pollock" and 
Boyle et al." showed considerable improvement after chelation, possibly due to re-
duction of calcinosis. These two cases however, particularly Pollock's, had more 
characteristics of systemic sclerosis than those of polymyositis. Winder and Curtis'" 
also noted improvement in calcinosis secondary to dermatomyositis in one of two 
patients treated by them. Chelation therapy also has been found to be effective in 
other hypercalcemic states, particularly sarcoidosis, '^ and was very effective in one 
patient of ours with hyperparathyroidism and severe post-operative hypercalcemia. 
Scattered case reports, especially in the foreign literature" " " " " ' ' ' ' ' ' attested to the 
efficacy of chelation in small series of patients with systemic sclerosis, including 
Fonceca's" report of improvement in electromyographic findings. The current interest 
in this subject, however, was stimulated by the totally unexpected finding by Price 
et al.'° that the three patients being treated by Rukavina et al.^' showed evidence 
of a gross disturbance in tryptophan metabolism, and that this was partially or 
totally corrected by chelation therapy. 
This paper is concerned with reporting the effectiveness of disodium EDTA 
and/or pyridoxine in the therapy of fourteen patients with systemic sclerosis. In 
addition, a discussion of recent work as reported in the current literature, is included 
in an attempt to explain the efficacy of chelation in respect to possible pathogenetic 
mechanisms in systemic sclerosis. 
MATERIALS AND METHODS 
Thirteen patients, one male and twelve females, varying in age from fourteen to sixty-
five years, were treated with one to five courses of di.sodium EDTA. One patient received 
only pyridoxine, 100 mg. per day. Three grams of disodium EDTA in 500 cc. glucose in 
water was given over a three to six hour period daily for five days. If the course was longer 
than five days, a two day rest followed each five days of treatment. In three patients, 
(S.G., A.I . . and S.D.) treatment was given once weekly or biweekly following the initial 
course or courses. A summary of the treatment program is included in Table I . 
Pyridoxine has been given in daily doses of 50 to 100 mg. per day to eight of the 
thirteen patients during and following chelation therapy. 
In addition to the usual routine studies, special examinations were performed as indicated 
to define the extent of the disease process. Other than frequent routine urinalyses, and 
periodi; measurement of blood urea nitrogen, no specific precautions were taken during 
therapy. 
RESULTS 
The results of therapy with disodiuiu EDTA and/or pyridoxine in our fourteen 
patients are summarized in Table I . While it is true that the results were generally 
better in those patients with predominantly acrosclerotic involvement; nevertheless, 
definite improvement was noted in all organ systems affected. lohnson" states that 
possibly acrosclerosis and systemic sclerosis are different diseases, and if true, this 
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Tot.125 i n g f o r 1 y r . 
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S.L. 
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S.D. 
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m o t i l i t y . 
•para-amino- 9/60 5 15 
benzoic acid.5/61 15 ^5 
Vasodilators Tot,90 
Increased m o b i l i t y 
a f t e r each course. 
No change i n 
pulmonary symptoms. 
Defin i t e decrease i n 
pain and calcinosis. 
kh 10 Generalized sclerosis, Raynaud's, 
moderate pulmonary f i b r o s i s , 
myopathy, dysphagia, generalized 
a r t h r a l g i a . 
V i t , E 
Steroids 
Testo-
sterone . 
Potassium 
para-araino-
benzoate. 
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2/60 7 21 
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Fair! 
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may account for the variation in effect of chelation therapy. Winklemann' and Winder 
and Curtis'" also noted a comparative lack of response in manifestations other than 
acrosclerosis. 
As also noted by Muller et al.,^' response to therapy did not seem to be related 
to the duration of symptoms prior to therapy. Whereas, only eight of their twenty 
patients with acrosclerosis and one of two with diffuse disease showed improvement, 
our results were considerably better. This may be due to the fact that most of their 
patients received only 35 to 50 gms. disodium EDTA in total. Indeed, they report 
50 per cent improvement in two of three patients who received over 100 gms. 
Most of our patients showed initial improvement during the first week of therapy, 
but in contrast to the report of Winder and Curtis,'" those that did not respond in 
the early stage did show improvement after prolonged therapy. This deferred response 
was also noted by Depondt et al.^' in one of their two patients, no effect being noted 
until after the administration of 60 gms. of disodium EDTA. Winkelman' also noted 
reversal of esophageal motility to normal in one patient only after three months of 
therapy. 
The observation by Jaffe and Winkelmann^" that better resuhs are noted in 
children than in adults was not confirmed by our experience with patient G.H., 
although she had systemic manifestations rather than acrosclerosis and did show a 
good reversal of the skin involvement. 
Follow-up in this group varied from two to 32 months following initial therapy 
except for patients H.B. and S.H. who were lost to further study. Seven patients 
have received only one course of treatment with good or excellent results maintained 
from two to 17 months. Two patients, S.G. and S.L., have received three courses of 
therapy because of recurrence of symptoms from two to 15 months after a previous 
course with equally good results from subsequent therapy. The other five patients 
have been treated with additional courses because of only partial response to the 
first program and/or reversal of some of the initial improvement. Each has shown 
some further response to subsequent therapy. 
Those patients with major involvement of organs in addition to the skin did 
not show as good results in these areas as they did in the skin. Patients, S.G., S.H., 
P.W., G.H. and S.L., with marked myopathy, all required continuation of steroid 
therapy to control this manifestation. Patients, C.F., S.L. and S.D., with severe 
pulmonary involvement, showed some improvement in this area (Table I I ) . 
Patient, S.D., has shown the poorest response. This may be due to the severe 
pulmonary insufficiency present prior to treatment, which has slightly improved with 
therapy. However, this improvement may be due to the increased mobility of the 
chest cage rather than to any effect on the lung parenchyma. 
Other than one severe hypocalcemic episode, rapidly corrected by intravenous 
calcium gluconate, and one episode of hypotensive syncope, no serious complications 
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were encountered. Further therapy in the two patients wi th the above complications 
was uneventful. As did Meltzer et al.^^ in their series of 2,000 infusions, we en-
countered frequent burning along the course of the vein used for injection. This 
was easily controlled (except in one patient not included in this series, who was 
unable to tolerate disodium E D T A because of this burning) , by slowing the rate 
of infusion, or by diluting the three gms. of disodium E D T A wi th 1,000 cc. of f lu id . 
Antihistaminics also prevented this unpleasant side-effect in some patients. M i l d 
nausea and abdominal cramping were noted occasionally as in Meltzer's^^ group. We 
did not observe any of the other toxic effects noted by S e v e n . H e lists, in addition 
to those noted above: thrombophlebitis, renal tubular damage, systemic febrile re-
actions, glycosuria, anemia, dermatitis, diuresis, coagulation defects, calcium emboli 
and decreased digitalis effect. 
CASE REPORTS 
CASE 1 (A.P.) — A 44 year old, white housewife, was first seen in November 1958. 
complaining of Raynaud's phenomenon, ulceration and severe pain in the left thumb and 
decreased hand mobility. Past history revealed that Raynaud's phenomenon had begun in 
1943 at which time two fingernails were removed because of pain. A right dorsal sym-
pathectomy was performed in June 1958. Because of severe pain, the distal digit of the 
right second finger was amputated in October, 1957. Severe pain had continued in various 
digits and several had become ulcerated with subsequent healing. System review was 
otherwise negative except for bilateral deafness. 
Examination revealed bilateral trophic hand changes with tight, shiny skin, ulceration 
of the left thumb and generalized cyanosis of the fingers. There was telangiectasia of the 
skin of the face, neck and back. Blood pressure was 160/105 mm/Hg. Cardiac examination 
was normal except P2 was split and louder than A2. The remainder of the examination 
was normal. 
Hemoglobin was 15.7 gms per cent; white blood cell count was 9,500 per cu rnm with 
a normal differential; urinalysis was normal; sedimentation rate was 25 mm/hr (Wintrobe). 
cryoglobulins and LE cell tests were negative. Serum protein electrophoresis was normal. 
BSP retention was 3 per cent. Non-specific ST segment changes were present in the 
electrocardiogram. X-rays of the hands showed ischemic, atrophic changes in all tufts with 
soft tissue tapering and atrophy. 
She was treated with vasodilators and sedadon, pain medications and local measures 
until Apri l , 1960. at which time severe pain and ischemic ulceration of the left index 
finger and flexion contractures of all five left fingers caused readmission. A left stapedectomy 
had been performed for otosclerosis in July 1959, with good results. She also complained 
of increasing dyspnea. Examination was unchanged except for a 0.5 x 2 cm ulceration of 
the left index finger, heliotroping of the eye lids, and calcinosis in the pad of the left 
f i f th finger. There were flexion contractures of all five fingers of the left hand. 
Hemoglobin was 13.9 gms per cent and white blood cell count was 7,100 per cu mm 
with a normal differential. The urinalysis was normal except for a few white, red and 
epithelial cells. Serum G.O. transaminase was 7 units and C-reactive protein was 3.5 units. 
Cryoglobulins were 2+ at 72 hours. BSP retention was 1 1 per cent and the 24 hr. urinary 
creatinine/creatine ratio was 8.55. Serum protein electrophoresis showed an increase in 
gamma globulin to 1.81 gms and a decrease in albumin to 3.82 gms. The electrocardiogram 
now showed right ventricular hypertrophy. Chest x-ray revealed cardiomegaly and increased 
pulmonary vasculature. Spirometry showed VC, TVC and MBC to be normal. X-rays of 
the hands revealed, in addition to the tuft changes, calcinosis in the left fourth and f i f th 
and right third, fourth and f i f t h fingers. An electromyogram was compatible with myopathy, 
but muscle biopsy was normal. Biopsy of the skin revealed some papillomatosis, but was 
otherwise normal. 
Treatment consisted of fifteen daily infusions of 3 gms. disodium EDTA for a three 
week period, plus phenobarbital for sedation. Pain was relieved prompdy and mobility of 
hands was improved. 
Four months later the patient reported the "best summer in years." Mobility remained 
good and the ulceration of the left index finger was dry. One year later, without further 
treatment, the only symptom was a slight fissure of the right middle finger. 
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u J ? 5,^ ^ : fourteen months after treatment, the patient continued improved, but 
had developed slight dysphagia. Esophageal x-ray showed decreased peristalsis of the 
lower esophagus and a small hiatal hernia. Antacid therapy was effective. "When last seen 
in October, 1961, she had no symptoms except slight ankle edema. Mobility of the hands 
and softening of the skin remained improved. 
CASE 2 (E.K.) — A 48 year old, white housewife, was first seen in May. 1960, com-
plaining of stiffness, numbness and tingling in the fingers and hands with some weakness 
ot the hands and arms for six weeks. Except for soreness of the left knee for the preceding 
six months, past history was unremarkable. Physical examination was entirely normal. 
She was next seen in April, 1961, with swollen, stiff skin of the hands. The initial 
symptoins had persisted, but no others had developed. Exaraination was again normal except 
tor tightness and atrophy of the skin of the fingers and dorsum of the hands. 
Hemoglobin was 13.9 gms per cent; white blood cell count was 5,500 per cu mm with 
a normal ditterential. Urinilysis was normal. Sedimentadon rate was 30 mm/hr (Wintrobe) 
and a latex fixation test was negative. Uric acid was 6.5 mg per cent; serum calcium, 9.2 rag 
One moiith later the patient developed swelling of both wrists and hands with turgid 
tense, shiny skin. Examination was unchanged except for medium and coarse rales in both 
lower posterior lung fields. P2 was now louder than A2. but the heart was otherwise normal 
per cent; .serum phosphorus, 3.8 mg per cent. X-ray of the chest showed fluid at the right 
costophremc angle and esophageal study revealed a small hiatal hernia. 
Hemoglobin was 13.1 gm per cent; white blood cell count was 4,950 per cu mm with 
cent eosttiophtls. Urinalysis was normal. Sedimentation rate was 45 mm/hr (Wintrobe) 
and the latex fixation test became weakly reactive. LE cell tests were negative and the 
serura O.O. transarainase was 10 units. Twenty-four hour urinary creatinine/creatine ratio 
was t . i and a muse e biopsy revealed early changes of rayopathy without fibrosis or 
vasculitis rhe skm showed homogenization of the dermal collagen and mild round cell 
perivascular intiltraUon. Bone marrow exaraination was norraal except for hypercellularity 
and decreased M:E ratio to 2:1. Serum protein electrophoresis was normal except for an 
elevatiori of gamma globulin to 1.73 gm. Chest x-rays revealed resolving pneuraonitis in 
tne right base with a small amount of fluid and there were a few atelectatic strands at the 
lert base, bxcept tor the sraall hiatal hernia, an upper gastrointestinal series was normal. 
An electrocardiograra was within norraal limits. 
^J^^ patient was discharged on 100 mg of pyridoxine per day and became asymptomatic 
^ . ^ ^ u ^^'^A u"^'' months after beginning therapy, in September. 1961, she was asympto-
^,7t^' .V," . .u uP'l°'^^ °^ pleurisy in the right posterior chest. X-ray now showed 
cystic changes at the right base. 
c,;ffn^.''°"r l l " ' t ^ ^ ' l in December, 1961, she remained asymptomatic except for minimal 
stiffness of the hands. Examination was unremarkable. 
CASE 3 (C.T.) — A 59 year old, white housewife, was first seen in August, 1961. She 
complained of Raynaud s phenomenon which had begun three years earlier and increased 
in severity two months prior to admission. Past history revealed lifelong asthraa and mild 
hypertension for ten years. She also had moderate exertional dyspnea. 
.tr^na,h''h,''J''''°" ' ' ^ ^ f ^ ' ^ ' i shiny. tight, atropic skin on the right hand, with decreased 
strength but no muscle atrophy. Tenderness was present over the right biceps tendon, but 
shoulder motion was normal. There were crepitant rales at both lung bases and the 
Drecinh«Ted''fc,H ^"^1, ^ ^ t f * ^ i , "S'^ ^ •"^•"S'"' Raynaud's phenomenon wal precipitated by cold in both hands. The remainder of the findings were normal. 
Hemoglobin was 13 4 gm per cent; white blood cell count was 9,800 per cu ram with 
a nortnal differential. Urinalysis revealed a few red and white cells, but was otherwise 
normal. Sediraen ation rate was 16 mm/hr (Wintrobe). Cryoglobulins and LE cell tests 
were negative. Alkaline phosphatase, serum calcium and phosphorus, blood urea nitrogen 
i ^ ' ^ ^ ^ o l " ' a n d serum protein electrophoresis were normal. An electrocardiogram was 
H^hT i ; 1:,''''^^° chest revealed sclerocystic changes at both bases, and those of the 
right shoulder sho\yed only bony atrophy. Esophageal studies showed decreased peristalsis 
and delayed etnptying of the lower third. Skin biopsy revealed hyperkeratosis, focal para-
keratosis and flattened rete ridges. The dermis was nomal. 
Treatment consisted of a five day course of disodium EDTA, vasodilators and sedation 
the patient claimed complete relief of symptoras after the third infusion and was objectively 
normal on examination after the fifth treatment. She was discharged on 100 mg of pyri-
doxine per day and has remained without symptoms. 
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Figure 1 
Patient #4, M.D.; Inability to close fist prior to chelation therapy. 
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CASE 4 (M.D.) — A 61 year old, white housewife, was first seen in December, 1961, 
with complaints of progressive Raynaud's symptoms for five years. She had noted weight 
loss, dysphagia, generalized arthralgia and hght tan stools for four to six months. 
Examination revealed atrophic, shiny, tight skin of both hands (Figure 1), and to a 
lesser extent of the toes. Skin of the neck and scalp was tight. Blood pressure was 
170/105 ram/Hg and there were moist rales in both posterior lung bases. The remainder 
of the findings were normal. 
Hemoglobin was 10.5 gm per cent; white blood cell count was 5,150 per cu mm with 
a norraal differential. Sediraentation rate was 37 ram/hr (Wintrobe); urinalysis was norraal. 
Serura G.O. transarainase, serum calcium and phosphorus, BSP retention and protein bound 
iodine were normal. LE cell tests and cryoglobulins were negative. Latex fixation was 
reactive. Serum carotene was 92 mg per cent; 72-hour fat excretion was 11 per cent. An 
electrocardiogram was normal. Serura protein electrophoresis showed a decrease in albumin 
to 3.0 gm and an increase in alpha-2 globulin to 1.01 gra, gamma globulin to 1.98 gm. 
X-rays revealed fibrocystic changes at both lung bases and there was demineralization of the 
bones of the hands. Gastrointestinal series revealed a dilated distal esophagus with decreased 
peristalsis, and norraal storaach small bowel, and colon. Biopsy of the skin revealed slight 
hyperkeratosis, focal condensation of collagen in the dermis and condensation of elastic 
fibers. Esophageal and stomach mucosal biopsy revealed an increase of plasma cells in the 
tunica propria and there were xanthomatous cells in the duodenal submucosa. 
Four days following completion of ten infusions, a total of 30 gm of disodiura EDTA. 
there was definite improvement in skin tightness and increased mobility of the hands 
(Figure 2). Pyridoxine, 100 mg per day, was begun at the onset of therapy and has 
been continued. When last seen two months following therapy, there was continued im-
provement in skin texture and no pulmonary or gastrointestinal syraptoms. Minimal Raynaud's 
phenomenon persisted and vasodilators were begun. 
CASE 5 (H.B.) — This 39 year old, white female, a furniture sander, had noted progressive 
Raynaud's symptoras in both hands and feet for four years prior to being adraitted in 
December, 1959. A right dorsal sympathectomy had been performed in December, 1957, 
and the left dorsal chain was excised in June, 1958, but without help. In the year prior 
to admission, small ulcerations developed under several finger nails and there had been a 
twenty pound weight loss. Vasodilators had been of no help. She complained of mild 
exertional dyspnea, but not of dysphagia. 
Examination revealed tight, shiny, atrophic, skin of the hands and face. There was 
recurrent Raynaud's phenomenon and several small ulcers were noted at the tips of the 
finger pads. Dullness and decreased fremhus was noted at the right posterior lung base 
and P2 was louder than A2. The rest of the findings were unremarkable. 
Hemogobin was 12.1 gra per cent; white blood cell count was 10,000 per cu rara with 
a norraal differential. Urinalysis, cryoglobulins, serum G.O. transaminase and VDRL were 
normal. Twenty-four urinary creatinine/creatine ratio was 11.2. An electrocardiograra 
showed first degree heart block. The chest x-ray was normal and an esophageal study 
revealed decreased motor activity and delayed emptying. Electromyography was compatible 
with myopathy. Biopsy of the skin showed thin epidermis, flattened rete pegs and slight 
lymphocytic infiltration of the dermis. Muscle fibers were norraal, but there was increased 
collagen tissue between the fibers. 
Bilateral stellate ganglion blocks were performed in December, 1959, with excellent, 
but transient, relief of the Raynaud's phenoraenon. Nine infusions of disodium EDTA. a 
total of 27 gm were completed in January, 1960. There was marked increase in skin 
ela.sticity and hand mobility and norraal raobility of the face. . \ \ { ulcerations healed, but 
moderate Raynaud's syraptoms persisted and she was discharged on va.sodilators plus 50 rag 
of pyridoxine per day. 
CASE 6 (A.M.) — A 42 year old, white stenographer, was first seen in December, 1961. 
Sixteen months prior to her admission she had developed swelling of the hands, face and 
ankles, stiffness and tightness of the skin of the hands, feet and face, and marked Raynaud's 
phenomenon in response to cold or anxiety. A l l large joints became painful and stiff, there 
was raorning gelling, and the skin became tight and shiny. The hands were so immobile 
that she was unable to type (Figure 3a). She was unable to masticate sorae foods due to 
stiffness of the perioral skin (Figure 3b), and dysphagia was noted. Twenty-five pound weight 
gain was noted due to inactivity. Treatment had consisted of steroids, potassium para-
arainobenzoic acid, vasodilators, quinine and tranquilizers despite which the syraptoms 
gradually progressed. Steroids were discontinued one month prior to adraission. 
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Figure 2 
Patient #4, M.D.; Improved mobility of hand following 30 gm disodium EDTA. 
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Figure 3A 
Patient #6, A.M.; Inability to close fist and tight, shiny skin prior to therapy. 
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Examination revealed tight, shiny, atrophic skin of the hands, arms, chest, shoulders, 
neck and face; flexion deformities of the fingers (Figure 3a), and severe Raynaud's pheno-
raenon. There was pain about the hips limiting straight leg raising to 70 degrees bilaterally. 
The reraainder of the findings were normal except for a moderately enlarged, multinodular 
goiter. 
Hemoglobin was 12.6 gm per cent; white blood cell count was 5,900 per cu mm with a 
normal differential. Urinalysis, protein bound iodine, latex fixation, blood urea nitrogen, 
seruin calcium and phosphorus, and serum protein electrophoresis were normal. An electro-
cardiograra was normal. Chest x-ray was negative. Esophageal films revealed absent peri-
stalsis in the distal half of the esophagus. 
Disodium EDTA was administered in daily doses of 3 gra for ten days. Severe burning 
along the course of the vein was controlled by dilution to 1.000 cc and antihistamines. 
Pyridoxine, 100 rag per day, vasodilators and salicylates were adrainistered concomhantly 
and on discharge. 
Marked increase in skin raobility and softness and increased joint motion was noted 
by the end of the course (Figure 3c, 3d), and had continued to improve over a two month 
period. Minimal Raynaud's symptoras persisted. The patient was able to return to her 
norraal work as a typist on discharge. 
CASE 7 (S.G.) — A 42 year old, white housewife, was first seen in 1944, com-
plaining of pain in the right shoulder and wrist and swelling of the right wrist for one 
month prior to admission. Diphyllobothriura latum infestation was noted and successfully 
treated. Past history revealed only frequent fainting spells. Exaraination was normal except 
for limitation of motion of the right shoulder and a painful, cystic, swelling of the right 
wrist. X-rays showed cystic changes in the wrist and shoulder. The hemoglobin was 13.3 
gm per cent; white blood cell count was 14,250 per cu mm with a normal differential. 
One month later intermittent contractures and swelling of the right hand and fingers 
were noted. Chest x-ray was negative and serum calcium and phosphorus were norraal. 
Figure 3B 
Patient #6, A.M.; Inability to open mouth adequately prior to therapy. 
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Figure 3C 
Patient #6, A.M.; Improvement after 30 gm disodium EDTA. 
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Figure 3D 
Patient #6, A.M.; Improvement after 30 gm disodium EDTA in mobility of skin and increase in 
oral aperture. 
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With no specific therapy, she remained symptom free for six years except for occa-
.sional aching of the left shoulder and neck muscles. In 1950, steroid therapy was instituted 
by another physician for fluctuating stiffness, pain, and swelling of both arms, wrists knees 
and neck, with stiffness of the neck and paresthesias of the arms and hands. This was 
discontinued in 1952, and symptoras gradually progressed. 
She was next seen in May, 1958, with symptoms as noted above. Examination 
revealed the skin to be thick and dry. There was swelling and limited raotion of the 
wrists and elbows and stiffness of the neck. Chest and spine x-rays were negative Treatraent 
was refused and patient was not seen again until June, 1959. At this time she coraplained 
ot marked tightness of the skin of the neck, scalp, shoulders, back, chest, and arras-
dysphagia, dyspnea, and generalized joint pain and limitation of motion. Examination 
revealed tightness and atrophy of all skin frora the waist up. with tapered, tight shiny 
fingers, but was otherwise unremarkable. 
Hemoglobin was 12.3 gm per cent; white blood cell count was 10,450 per cu ram 
with a normal differential. Latex fixation was weakly reactive. Urinalysis. VDRL, serum 
alkaline phosphatase, blood urea nitrogen, serum creatinine, fasting blood sugar protein 
bound iodine and serum protein electrophoresis were norraal. Spiroraetry was within normal 
limits and chest x-ray was negative. Spine x-rays showed mild osteoarthritic changes and 
the wrists and hands showed the same cystic changes as noted previously. X-ray of the 
esophagus was normal. Skin biopsy revealed hyperkeratinization, decreased prominence of 
the rete ridges, sclerosis of the dermis and increased fibrous tissue in the lower portion 
ot the dermis. 
Following 21 gm of disodium EDTA over a seven day period, there was marked 
decrease in joint and rauscle soreness and normal skin texture and mobility except for 
an area over the occipital notch. She was discharged on salicylates, but after two months 
noted recurrence of skin tightness as well as muscle soreness and weakness. 
Electroniyography at this time was compatible with myopathy. Patient received six 
daily 3 gm infusions of disodium EDTA without incident except for a severe hypotensive 
episode during the second. No treatraent for this was given and following one day of rest 
the four reraaining infusions were given whhout incident. The skin again cleared except 
tor the tightness over the upper neck, but muscle symptoms remained. Patient was dis-
charged on steroids and para-aminobenzoic acid. She reraained relatively asymptomatic 
tor 15 months but in November, 1960, again noted increasing tightness in the previously 
noted areas, particularly the neck, shoulders and scalp. Examination was unchanged except 
tor return of generalized skin tightness from the waist up. 
Heraoglobin was 12.2 gm per cent; white blood cell count was 12,350 per cu mm 
with a norraal differential. Urinalysis, serum calcium and phosphorus, blood urea nitrogen 
sedimentation rate, and serum carotene were normal. Chest and skull x-rays and an 
electroencephalogram were normal. She received 30 gm of disodium EDTA over a ten 
day period with no complications except mild nausea and vomiting, controlled sympto-
matically The skin again became norraal except for tightness over the occiput. She was 
drscharged on pyridoxine, 100 mg per day, and steroids as before. 
Patient remained asymptomatic and did not return for eleven months, when in 
Noveraber 1961, all syraptoms plus slight dyspnea and dysphagia, had returned. She had 
continued to take steroids and pyridoxine. Hemoglobin, white blood cell count serum 
calcium and phosphorus, fasting blood sugar, blood urea nitrogen, urinalysis and serum 
protein electrophoresis were normal. During November, she received three courses of 
therapy in sixteen days with interval rest periods for a total of 48 gra of disodium EDTA 
Steroids and pyridoxine were continued. Iraproveraent was again noted with only residual 
c A ^ f *® occiput and raild rauscular aching. Infusions of 3 gm of disodium 
bDLA were given once a month on discharge and when last seen in Eebruary 1962 im-
provement had been maintained. 
CASE 8 (S.H.) — This 38 year old, white housewife, was admitted on June 5, 1961 with 
a chief complaint of hardness of the skin of the abdomen, upper thighs and chest for three 
months. Shortly before admission, she had noted stiffness, swelling and aching of the 
extremities and swelling and stiffness of the hands. Two years prior to admission a carcinoma 
ot the cervix had been discovered and treated with radiura. A hysterectomy was performed 
one year later. 
Examination revealed mild heliotroping of the eye lids, induration and hardening of 
the skin of the abdomen and thighs and to a lesser degree on the chest, neck, face and 
540 
SYSTEMIC SCLEROSIS 
arras. There was an occasional wheeze in the right posterior lung field and the reraainder 
of the findings were normal. 
Heraoglobin was 11.4 gra per cent; white blood cell count was 9,150 per cu ram with 
a normal differential. Urinalysis, VDRL, fasting blood sugar, blood urea nitrogen, serura 
creatinine, serum G.O. transaminase, LE cell tests and BSP retention were normal. Sedi-
raentation rate was elevated to 26 rara/hr (Wintrobe). Serura protein electrophoresis revealed 
decreased albumin to 2.55 gra and increased garama globulin to 1.75 gm. Twenty-four 
hour urinary creatinine/creatine ratio was 1.72. X-rays" of the chest and esophagus were 
normal. An electrorayograra was compatible with myopathy. 
Following administration of 30 gm of disodiura EDTA, there was marked improvement 
in skin softness and raobility. Myopathic syraptoras remained and the patient was dis-
charged on steroid therapy. 
CASE 9 (A.J.) — A 36 year old, white, raale engineer, was first seen in August, 1961. He 
complained of gradually increasing Raynaud's syraptoms over a two year period with gradual 
stiffness of the hands, feet, and wrists, and gradual progressive tightening of the skin 
generally. The finger tips were painful. He had also noted mild dyspnea and chest pain 
on deep inspiration. 
Exaraination revealed tight, atrophic, shiny skin of the face, arras and hands, helio-
troping of the eye lids, telangiectasia of the neck and chest, and cyanosis of the nail beds. 
The remainder of the findings were normal. 
Hemoglobin, white blood cell count, differential, urinalysis, VDRL, and chest x-ray 
were norraal. 
He was treated with UML-491. 6 rag per day, until Noveraber, 1961, with initial 
decrease in Raynaud's phenoraenon and increase in skin softness. Subsequently, increased 
tightness of the skin, pain and cyanosis of the right foot developed, and he was unable 
to open his raouth norraally. 
In November, 1961, symptoms were quite severe. Hemoglobin, white blood cell count, 
urinalysis and serura creatinine were norraal. Chest x-ray showed a diffuse fibrotic inf i l -
tration raore raarked at the bases. Esophageal x-rays revealed decreased peristaltic activity 
in the lower half, and small bowel series showed sacculations and delayed eraptying of one 
segraent. 
There was definite subjective iraproveraent and loosening of the skin after 12 gm of 
disodium EDTA were given in four days. Two additional 12 gm courses resulted in moderate 
iraproveraent with increased raobility and looseness of the skin. This improvement persisted 
for three months, but all findings returned to pretreatment levels in Eebruary, 1962. A 
further 12 gm course resulted in slight improvement. A 3 gm infusion of disodium EDTA 
per week since then has resulted in definite slow improvement in all symptoms and findings. 
CASE 10 (P.W.) — A 38 year old, white, housewife, when first seen in October, 1959. 
had had symptoras of Raynaud's phenomenon for two years, stiffness of the wrists and 
fingers for three months, and shoulder stiffness for one week. Examination was unremarkable 
except for eye lid heliotroping and tightness of the skin of the hands and forearms. Ulcerated 
areas opened into both olecranon bursae. 
Hemoglobin was 12.0 gm per cent; white blood cell count was 4,200 per cu ram with 
a normal differential. Urinalysis, blood urea nitrogen, fasting blood sugar, LE cell test, 
serum calcium and phosphorus, serum G.O. transarainase, 'VDRL, protein bound iodide 
and BSP retention were norraal. The sediraentation rate was elevated to 36 rara/hr 
(Wintrobe). Twenty-four hour urinary creatinine/creatine ratio was 1.83. Serura protein 
electrophoresis showed elevation of gamma globulin to 2.03 gm. An electrocardiogram was 
normal. Electromyography was compatible with rayopathy. Chest, upper gastrointestinal 
and colon x-rays were norraal. X-ray of the hands revealed a sraall cystic area in the tuft 
of the right third finger. Skin biopsy showed thinning of the epiderrais, ederaa and atrophy 
of the derrais and a slight lymphocytic infiltration. Muscle biopsy revealed extensive 
degenerative changes with atrophy, vacuolization of fibers, hyalinization, phagocytosis and 
a lymphocytic infiltration. 
Disodium EDTA was administered over a six day period for a total of 18 gm. She 
was discharged on vasodilators and potassium para-aminobenzoate and noted a progressive 
softening of the skin, increased mobility of the hands and healing of the olecranon ulcers. 
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Dermatitis, secondary to potassiura para-aminobenzoate developed after one month and this 
therapy was discontinued. A second course of 15 gm of disodium EDTA was administered 
in November, 1959, and steroid therapy was instituted for the myopathy. Progressive im-
provement continued through May, 1960, and steroids were discontinued. Myopathic symptoms 
of muscle weakness and pain recurred in November, I960, with some increased skin tightness. 
Heraoglobin was 12.8 gms per cent; white blood cell count was 7,700 per cu mm with a 
norraal differential. Urinalysis, serura calciura and phosphorus, serura alkaline phosphatase, 
fasting blood sugar, blood urea nitrogen and chest x-ray were norraal. 
Steroids were restarted and she received 9 gm of disodiura EDTA over a three day 
period. Progressive improvement again was noted and with the exception of mild Raynaud's 
phenomenon, she was asymptomatic. When last seen in December, 1961, the skin remained 
quite flexible and there were few myopathic symptoms. Low dosage steroid therapy was 
continued. 
CASE 11 (G.H.) — A 14 year old, white female, was admitted on July 6, 1959, with a 
chief complaint of fever to 103° E, swelling of the hands, feet, lower legs and face, and 
weight loss of one month's duration. Past history was unremarkable. 
Exaraination revealed tense, hard, shiny skin and swelling of the forearras, hands, lower 
legs, feet and face. There was no rauscle pain or tenderness. Teraperature was 103° E. 
The findings were otherwise norraal. 
Heraoglobin was 9.8 gm per cent; white blood cell count was 4,500 per cu mm with 
29 per cent eosinophils. Bone marrow examination was unreraarkable except for eosino-
philia. Sedimentation rate was 21 mra/hr (Wintrobe); hematocrit was 45 per cent. Urinalysis, 
C-reactive protein, VDRL, serura calciura, protein bound iodide, LE cell tests and serum 
creatinine were normal. Latex fixation was weakly reactive. BSP retention was 8 per cent 
Serum protein electrophoresis showed decreased albumin to 2.19 gm per cent and increased 
gamma globulin to 2.99 gra. Serura G.O. transarainase was 36 units, 24-hour urinary 
creatinine/creatine ratio was 3.07 and an electrorayograra was corapatible with rayopathy. 
X-rays of the chest and hands were norraal. PPD #2 and trichinella skin tests were 
negative. Skin biopsy revealed thick derrais with collagenous thickening, sclerosis and horao-
genization. Perivascular lyraphocytic and plasraa cell infiltration was present. There were 
areas of calcification in the dermis. Muscle fibers showed degeneration, phagocytosis, 
sarcolemraal proliferation and central migration, and there was interstitial lyraphocytic 
infiltration. 
The patient became asymptomatic on steroid therapy, but brawny thickening of the 
skin persisted. She was discharged on low levels of steroids and had continued increased 
strength. 
In Eebruary, 1960. increased woodiness of the skin and subcutaneous tissue was noted 
on all extremities, face and trunk. There was marked tightness of the skin and limitation 
of joint raotion. Heraoglobin was 12.7 gm per cent; white blood cell count was 7,800 per 
cu ram with a normal differential. Urinalysis was norraal. Steroids were continued and 
she also received 15 gra of disodiura EDTA in a five day period. Definite softening of 
the skin and increased joint raobility was noted. 
Four raonths later, in June, 1960. in view of sorae persistent tightness of the skin, an 
additional 15 gm of disodium EDTA was given over five days with additional loosening 
of the skin. Esophageal x-rays at this tirae revealed stiffness of the upper half of the 
esophagus. 
By December, 1960, the patient had retained the previous iraproveraent and all treat-
raent was discontinued. Two raonths later, Raynaud's syraptoras and slight muscle pain were 
treated with UML-491 without improvement. Increased stiffness of the skin, fever and 
erythematous rash required steroid therapy with remission two weeks later. Patient has 
remained relatively asymptoraatic with raild generalized woodiness of the skin since that 
time and when last seen in Noveraber, 1961. was doing well on maintainence steroid therapy. 
CASE 12 (C.F.) — A 65 year old, white housewife, was admitted in May, 1960, with a 
five year history of Raynaud's phenomenon, stiffness of the arms and hands, generalized 
paresthesias, subcutaneous nodularities along the proximal forearms, draining calcareous 
lesions of the fingers, and marked weakness. She also noted paroxysmal cough, dyspnea, 
anorexia, weight loss, and increased skin pigmentation. Steroids, vasodilators, and para-
aminobenzoic acid had been used over a one year period without help. 
Examination revealed tight, hard, brawny, skin of the hands, forearms and face. The 
thighs were edematous. A 5x4 cm single thyroid nodule was noted. There were decreased 
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breath sounds and coarse rales at the right posterior lung base. The liver was enlarged to 
10 era below the right costal raargin. Hand and arra motion was limited due to contractures 
and hard, subcutaneous nodules were present over the lower third of the forearms. 
Hemoglobin was 11.9 gra per cent; white blood cell count was 7,250 per cu mm with 
a normal differential. Sedimentation rate was 37 mra/hr (Wintrobe); heraatocrit was 41 
per cent. VDRL. blood urea nitrogen, serum uric acid, serura alkaline phosphatase, urinalysis, 
LE cell test, prothrorabin tirae, fasting blood sugar and protein bound iodide were norraaL 
I-I31 uptake was 22 per cent and scintograra showed an active, rauhinodular goiter. BSP 
retention was 6 per cent. Latex fixation was non-reactive and 24-hour urinary creatinine/ 
creatine ratio was 2.2. Serum protein electrophoresis showed decreased albumin of 3.18 gm 
and gamma globulin increased to 1.92 gm. X-ray of the chest showed fibrocystic basillar 
changes and a partially calcified, substernal, thyroid gland. Soft tissue calcification and 
fraying of the tufts of the index fingers were noted on hand x-rays. The esophagus showed 
decreased peristalsis and atonia, but the stomach and colon were normal. 
Steroids were continued and 30 gm of disodiura EDTA were given over a 12 day period. 
No objective improvement occurred, but the patient noted subjective iraproveraent in less 
pain and numbness of the extremities. 
Four months later increased cough and dyspnea developed and she received 15 gm of 
disodiura EDTA. No further iraproveraent was gained and findings were unchanged. BSP 
retention, however, was now normal. Steroid therapy was continued and potassium para-
aminobenzoate was added without improvement. Increased dyspnea and cough required 
readmission m May, 1961. Findings were essentially unchanged except for clubbing of the 
fingers and increased rales and bronchial breath sounds in both lungs. 45 gm of disodium 
EDTA was given over a three week period with improved finger motion, slight thinning 
of the skin and slight decrease in calcinosis. 
In July, 1961, she developed congestive heart failure and electrocardiograms revealed 
an anterior myocardial infarction. Treatraent with digitalis and sodiura restriction was 
effective and when last seen in December, 1961, patient's only complaint was dyspnea 
Objective findings were essentially unchanged. 
CASE 13 (S.L.) — This 44 year old, white saleswoman was first seen in Apri l , 1959, 
complaining of weakness, dyspnea and dysphagia for ten years. Past history revealed 'coarse-
ness of the skin noted six years previously, Raynaud's phenoraenon for four years, weight 
loss, and generalized arthralgia, ankle edema and chronic cough for three years. A skin 
biopsy six years prior to adraission resulted in a diagnosis of scleroderma and patient had 
received Vitamin E for three years without help. When first seen, she had been taking 
triamcinolone for three years with no iraproveraent. 
Exaraination revealed a thin, cachectic appearing, white feraale, with 3x3 era firra. 
thick plaques on each thigh, palraar erythema, generally increased skin pigmentation, helio-
troping of the eye lids and poikiloderma of the skin of the neck. The skin of the hands, 
arms and chest was thin, shiny, and tight. Generalized muscle weakness and atrophy were 
present. Dullness and decreased fremitus were noted at the left posterior lung base, both 
bases were low and bronchovesicular breath sounds were general. The remainder of the 
examination was norraal. 
Heraoglobin was 15.1 gm per cent; white blood cell count was 8.700 per cu rara with 
a norraal differential. Urinalysis. VDRL. blood urea nitrogen, serum sodium, potassium, 
carbon dioxide and chloride, PSP excretion, serura G.O. transaminase, LE cell test and 
basal metabolic rate were norraal. Sediraentation rate was elevated to 24 rara/hr (Wintrobe): 
hematocrit was 45 per cent. Serum protein electrophoresis revealed decreased albumin to 
3.26 gm and increase in alpha-2 globulin to 1.02 gm. Twenty-four hour urinary creatinine/ 
creatine ratio was 4.33. Pulmonary function studies are noted in Figure 4. Electromyography 
was consistent with rayopathy, but muscle biopsy w.as unremarkable. Skin biopsy revealed 
an increase in dermal collagen. Chest x-ray revealed flat diaphragms and bilateral old 
apical capping with marked emphysema. Electrocardiograms, upper gastrointestinal x-ray 
and intravenous pyelograms were norraal. 
Steroids were discontinued and patient received testosterone and saHcylates for one 
month, but increased rauscle pain and stiffness required the addition of potassiura para-
arriinobenzoate, which was ineffective. In July. 1959, steroids were re-started with decreased 
pain, but persistent dyspnea, dysphagia and weakness. Generalized skin tightness became 
more severe. 
In February, 1960, all syraptoms became worse. Laboratory examinations were un-
changed. In seven days 21 gra of disodiura EDTA were given with marked improvement in 
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skin elasticity and joint raobility. Dyspnea and dysphagia decreased. Improvement continued 
over the next two raonths. 
Dyspnea, rauscle weakness and pain increased in April , 1960. Heraoglobin was 15.1 gra 
per cent; white blood cell count was 7,200 per cu inra with a normal differential. Serum 
calcium and phosphorus, sediraentation rate, latex fixation, serum G.O. transaminase, LE 
cell test, serura sodiura, potassium, carbon dioxide and chloride were normal. Disodium 
EDTA was given over five days to a total of 15 gra. Iraproveraent was again noted and 
persisted for 11 months. Steroids were still required for muscle pain and weakness. 
Increased dyspnea, dysphagia and rauscle weakness resulted in readraission in March, 
1961. Examination was unchanged. Pulmonary function study showed definite deterioration 
as noted in Figure 4. Heraoglobin was 16.2 gra per cent; carbon dioxide corabining power 
was 28.6 voluraes per cent. 24-hour urinary creatinine/creatine ratio was 4.46. Serum 
calciura and phosphorus, sedimentation rate, blood urea nitrogen and serum protein electro-
phoresis were normal. Urinary 17-ketosteroids were 7.9 mg in twenty-four hours. 15 gm of 
disodium EDTA caused definite improvement in all symptoms which persisted for five months. 
Increase in skin tightness and dysphagia in October, 1961, resulted in a further course 
of chelation. 15 gra of disodium EDTA were given despite an episode of hypocalcemic tetany 
during the fourth infusion with a serum calciura of 6.9 mg per cent. This was rapidly 
reversed with 1 gra calciura gluconate intravenously and oral calcium, so that serura calcium 
was 9.0 mg per cent three days later. Steroids were discontinued, but despite ACTH stimu-
lation, urinary 17-hydroxysteroids were 7.5 mg one month later and muscle pain and weakness 
was severe. Steroids were reinstituted. 
In November. 1961, patient had a severe episode of psychogenic hyperventilation during 
which serum calcium was normal at 9.8 rag per cent. Pulraonary function studies had returned 
to norraal (Figure 4). When last seen in February, 1962. iraproveraent had been maintained 
and she was relatively asymptoraatic. 
CASE #14 (S.D.) — A 39 year old, white housewife, was adraitted to the Henry Ford Hospital 
in April . 1958. with a chief coraplaint of painful ulcerations of the buccal raucous raerabranes 
for six weeks. Examination revealed ulcerative, erytheraatous, vesicular lesions of the buccal 
mucous raerabranes. The face and neck were flushed with telangiectasia and there was 
periorbital ederaa. A f i rm 5x5 era mass was palpable just to the left of the umbilicus, fixed 
to the lumbar spine. 
Heraoglobin was 13.4 gm per cent; white blood cell count was 4,400 per cu mm with 
6 per cent eosinophils. Sediraentation rate was 26 mm/hr (Wintrobe). Serura protein electro-
phoresis; albumin — 2.96 gm; gamraa globulin — 1.63 gra; beta globulin — 1.25 gra; alpha-2 
globulin — 1.04 gm. LE cell tests and urinalysis were normal. Culture of the raouth was 
unrewarding. X-rays of the chest, spine, gastrointestinal tract and intravenous pyelograms 
were normal. 
Excision of a retroperitoneal lyraphangio-pericytoraa was accomplished on May 16, 1958. 
Skin and muscle biopsy at this time were normal. The oral lesions improved on steroids, 
but recurred following termination of therapy in June, 1958. Biopsy and darkfield examina-
tions of the lesions at this time were unrewarding. Reinstitution of steroids with penicillin 
resulted in complete healing of the lesions by December of 1958, when treatment was 
discontinued. 
Dyspnea, orthopnea and productive cough developed in October, 1958, and progressed 
over the next four months, requiring readmission in February. 1959. She also complained 
of wheezing, fatigue and malaise. Exaraination revealed thickening, induration, flushing and 
telangiectasia of the skin of the face and chest. There was increased AP diameter of the 
chest, intercostal and supraclavicular retraction, dullness and decreased breath sounds, and 
fine rales at both bases. P2 was louder than A2, pulse rate was 120, but the heart was 
otherwise norraal. 
Hemoglobin was 15.4 gm per cent; white blood cell count was 8,750 per cu mm with 
6 per cent eosinophils. Urinalysis, fasting blood sugar, blood urea nitrogen, serum calcium 
and phosphorus, serum protein electrophoresis, LE cell tests, serura G.O. transaminase and 
sweat chloride were norraal. Sputum was negative on bacterial and fungus culture and cell 
block. 24-hour urinary creatinine/creatine ratio was 3.0. Electrocardiogram showed T wave 
inversion in standard leads I I and I I I and slight generalized ST wave depression. Chest 
fluroscopy revealed low. flat diaphragms which moved less than I cm. prolonged expiratory 
phase, but no infiltrative lesions. Pulmonary function studies are noted in Figure 4. 
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Figure 4 
Schematic representation of tryptophan-niacin and tryptophan-serotonin pathways. 
Steroid therapy was restarted, and with supportive raeasures she iraproved over the 
next four raonths except for increased dyspnea and wheezing with upper respiratory infectious. 
Bronchoscopy at another hospital in June, 1959, was essentially norraal. She reraained 
essentially the same for the next eight months. In January. 1960, menorrhagia necessitated 
a diagnostic dilatation and curettage which showed only cystic endometrial hyperplasia. A 
cervical biopsy performed at this time showed chronic cervicitis and one focus of calcification 
in the cervix was noted. 
In March. 1961, sudden increase in dyspnea was noted and spirometric exaraination 
revealed increased airway obstruction (Figure 4). The symptoms of dyspnea and cough 
gradually increased requiring readmission in May, 1961. Examination was unchanged. Hemo-
globin was 15.0 gm per cent; white blood cell count was 8,850 per cu mm with a normal 
differential. Urinalysis, LE cell test, fasting blood sugar, blood urea nitrogen, sedimentation 
rate and an electrocardiogram were now normal. Chest x-ray showed no change. Biopsy 
of the lung revealed focal eraphyseraa with slight peribronchial rauscular hypertrophy. Diso-
diura EDTA, 21 gra in seven days, was given with definite loosening of the skin and decrease 
in pulmonary symptom.s. Steroids were discontinued. Two months later the patient had no 
syraptoras except mild exertional dyspnea and slightiy increased skin tightness. Weekly 
infusions of 3 gm of disodiura EDTA were given over a four week period in September, 
1961, and iraproveraent was raaintained. Pulmonary function studies perforraed in Deceraber. 
1961, showed rainimal improvement. 
The patient has reraained relatively asymptomatic since with the exception of increased 
dyspnea due to an upper respiratory infection in January, 1962, and one episode of severe 
Raynaud's phenomenon. Four more biweekly infusions of 3 gm of disodium EDTA were 
given during December, 1961 and January, 1962. When last seen in February, 1962, she 
was well except for an upper respiratory infection with increased dyspnea and cough which 
cleared with antibiotic therapy. 
DISCUSSION 
Fortunately, rather than discarding the results of their chance finding of abnormal 
tryptophan metabolite excretion in patients wi th systemic sclerosis, Price and his group^° 
carried on their studies in this disorder and have defined the nature of the abnormal 
metabolism. 
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Abnormality of Tryptophan-Niacin Cycle in Systemic Sclerosis 
Price^' has demonstrated that administration of the pyridoxine antagonists isoniazid 
or desoxy-pyridoxine results in excessive urinary excretion of the tryptophan meta-
bolites kynurenin, hydroxy-kynurenin, their acetyl derivatives and kynurenic acid and 
xanthurenic acid, after loading with L-trytophan. He has also found these abnormal 
tryptophan metabolites in some cases of carcinoma of the bladder, porphyria, pregnancy, 
disseminated lupus erythematosis and systemic sclerosis. 
In those patients whose altered tryptophan metabolism was due to pregnancy, 
bladder cancer, or pyridoxine antagonist administration, the excretion pattern was 
reverted to normal by the administration of pyridoxine. This was not invariably true 
in systemic sclerosis or porphyria, however. In their original patients. Price et al.™ 
found that the abnormal metabolism was corrected in one patient by chelation alone, 
in a second by addition of pyridoxine to the program after partial correction by 
chelation and the third patient responded with normal patterns after either chelation 
or pyridoxine administration. Price™ also found quantitative and qualitative differences 
in the abnormal products excreted by those patients with pyridoxine-antagonist induced 
abnormality or pregnancy from those with systemic sclerosis, lupus erythematosis, 
porphyria or cancer. This would seem to indicate that some factor other than pyridoxine 
deficiency is operative in systemic sclerosis. 
The Role of Pyridoxine in the Tryptophan-Niacin Pathway 
As noted in Figure 4, the major role of pyridoxine seems to be its action with 
kynureninase on the conversion of hydroxy-kynurenin to 3-hydroxy-anthranilic acid. 
Price™ has shown that under normal conditions, only 2 per cent of a 2 gm. loading 
dose of L-tryptophan is represented by increased urinary metabolites, yet in pregnancy 
49 per cent; isoniazide administration 44 per cent: porphyria 34 to 36 per cent; and 
in systemic sclerosis 10.5 per cent of such a dose is represented by an increase in 
abnormal urinary metabolites. The reason for this discrepancy appears to be that 
normally the great majority of tryptophan is converted to non-aromatic compounds, 
mainly carbon dioxide, by non-enzymatic metabolism of 3-hydroxy-anthranilic acid. 
Thus a block by ineffective kynureninase activity will result in increased hydroxy-
kynurenin and kynurenin with subsequent excretion of increased amounts of these 
compounds or their degradation products. 
Pyridoxine — Heavy Metal Inter-relationship 
Metzler=' has shown in vitro that pyridoxal, an amino acid and a suitable metal 
in solution form a metal complex, and that in pyridoxal dependent enzymes, pyridoxal 
appears to be combined with an amino or lysine group as an imine, thus possessing a 
site susceptible to metal ion inhibition. He and his group'" have proposed that the 
active form of pyridoxal phosphate may be combined with substrate and a cation. 
In this case, cation imbalance would affect pyridoxine activity. 
Correction of Abnormal Tryptophan Metabolism by Chelation 
Perry"' has shown increased urinary excretion of manganese, cadmium, lead and 
zinc in atherosclerotic patients treated with calcium, disodium EDTA. Price and 
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Brown"^ have noted that patients with systemic sclerosis have shown a marked increa.se 
in urinary zinc and copper, and Boyle et al.'^ have documented decreased tissue 
calcium following chelation. Johnson '^ has noted that in sarcoidosis, despite the 
benefits of chelation and reduction of hypercalcemia, no abnormality of tryptophan 
metabolism has been noted. It would appear, therefore, that the action of the 
chelating agent is to remove excess metal ions, rather than any direct effect on the 
tryptophan cycle. 
Stewart"' states that kynureninase has been activated by magnesium, and postulates 
that excessive calcium, zinc or other ions may result in a functional deficiency of 
magnesium. In view of the greater affinity of calcium and zinc as well as most 
of the other ions above magnesium for binding by the chelate, chelation would seem 
to be a means for correction of the ionic imbalance, thus allowing magnesium to 
react with pyridoxine and activate kynureninase. 
Perry and Schroeder"" have noted skin lesions resembling pyridoxine deficiency 
in patients treated for atherosclerosis over long intervals with disodium EDTA. These 
lesions were corrected by the administration of pyridoxine. Price and Brown"' postulate 
that this apparent contradiction can be explained in that, with normal metal balance 
prior to therapy, an imbalance was created by chelation. Thus chelation may have 
pyridoxine-like activity if it corrects an imbalance of cations, or anti-pyridoxine activity 
if it creates an imbalance. This dual activity probably explains why one patient in 
Price's series'" showed reversal to normal of tryptophan metabolite excretion after 
ten days of therapy, but reverted to an abnormal pattern after five more days of 
chelation. 
Serotonin as Alternate Pathway in Tryptophan Metabolism 
Fleischmajer and Hyman"^ have suggested that the role of serotonin in causing 
tissue edema may play some role in the etiology of systemic sclerosis, in that tissue 
edema is the first manifestation of sclerosis, followed by increased hyaluronic-acid 
mucopolysaccharide binding, sclerosis and then fibrosis. They note that although 
normally only 1 per cent of tryptophan is utilized in the serotonin pathway, in 
functioning carcinoid tumors up to 60 per cent may be utilized in this manner. Thus 
the heavy metal — pyridoxine block of the tryptophan-niacin pathway, in addition to 
causing increased excretion of abnormal kynurenin metabolites, could conceivably 
result in an increased production of serotonin by increased utilization of this pathway 
(Figure 4) . 
This proposal is supported by several case reports of systemic sclerosis in 
conjunction with a functioning carcinoid tumor, among them that of Zarafonetis 
et al." On the other hand, if serotonin alone is the responsible agent, all patients 
with a carcinoid syndrome should show associated systemic sclerosis. The efficiency 
of the pulmonary filter in abdominal carcinoid may prevent systemic serotonin levels 
of sufficient magnitude or duration to cause such and/or this group may not survive 
long enough. It would be informative to determine the incidence of sclerodermatous 
changes in functioning bronchial carcinoids compared with the abdominal-hepatic 
variety. 
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MacDonald et al."' have demonstrated that serotonin injected into the subcutaneous 
tissue of rats on a long-term basis produces definite fibrosis. Scherbel"" produced 
inflammation in rat connective tissue with short-term injections of serotonin and 
this effect could be blocked by 1-methyl-D-lysergic acid butanolamide (UML-491), 
or cyproheptadine, potent serotonin antagonists. In addition he noted a marked in-
crease in the local reaction to subcutaneous injection of serotonin in patients with 
connective tissue disorders, notably those with Raynaud's phenomenon and rheumatoid 
arthritis. This increased reactivity could be prevented by the prior injection of serotonin 
antagonists or reversed after serotonin injection by the same agents. 
Halpern et al."' intensively studied eleven patients with Raynaud's phenomenon; 
one secondary to systemic sclerosis, two secondary to rheumatoid arthritis, three second-
ary to arteriosclerosis obliterans and five with primary Raynaud's disease. They were 
unable to demonstrate an increase in endogenous serotonin or urinary 5-hydroxy-indol-
acetic acid. They suggest that serotonin plays two roles in the production of Raynaud's 
phenomenon: first, a local vasoconstriction and secondly, hastening of the reversal of 
vasoconstriction once it occurs. This was based on their findings that UML-491 injected 
before cold stress modified the prolonged response of the Raynaud's group, but UML-
491 given at the height of the attack prolonged the episode over that in the pretreated 
group or untreated controls. They also noted that patients with Raynaud's phenomenon 
had a much more pronounced drop in digital temperature and color response than 
controls when serotonin was injected into the brachial artery. Both groups showed 
a marked decrease in severity of symptoms if UML-491 was injected at the height 
of the reaction. Iproniazid, an amine oxidase inhibitor, on the other hand, prolonged 
the attack if given before stress and had only slight effect if given at the height of 
the episode, indicating some other factor besides serotonin is operative. The com-
bination of a potent sympatholytic agent, such as Hydergine plus a serotonin antagonist 
(UML-491) more rapidly reversed the symptoms after subcutaneous injection of 
serotonin, than if either drug were used alone. This would indicate that the sympa-
thetic nervous system plays a role whh serotonin in the production of Raynaud's 
syndrome, also suggested by their findings that stellate ganglion block diminished the 
response to cold stress. 
In view of the possible role thus suggested for serotonin in the pathogenesis 
of systemic sclerosis, it is of interest to note that our patient, S.D., presented initially 
with oral mucous membrane lesions and an abdominal lymphangio-pericytoma. What 
relation, if any, this has to the report of McCormick et al.=° of a malignant bronchial 
pericytoma containing four micrograms per gram of serotonin, is uncertain, but invites 
speculation. 
Rationale of Present Therapeutic Agents as Related to Disordered Tryptophan 
Metabolism 
In order to give a more rational basis to therapy, it would seem wise to attempt 
to integrate the presently used methods of therapy of systemic sclerosis into the above 
proposed pathogenic mechanism, not only to support their use, but to further sub-
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stantiate the proposal by indicating what part those agents have been found to be 
clinically useful play in correcting the faulty tryptophan metabolism. 
Chelation therapy has been found to be clinically useful in many instances. This 
may well be due to the observed reversal of the abnormal excretion of tryptophan 
metabolites. I t is suggested that this alteration may make the major pathway of 
tryptophan utilization, i.e., the nicotinamide pathway, more effective and thus require 
less utilization of the minor serotonin cycle. Further work to demonstrate the over-
production of serotonin in this situation if it exists, is necessary to substantiate this 
suggestion. I f such should prove to be the case, the variability of effectiveness of 
chelation as reported clinically may be related to the situation noted by Price et al.™ 
where reversal to normal of tryptophan metabolites occurred after chelation for ten 
days, only to revert to the abnormal pattern after five more days, interpreted by 
Price and Brown"' as correction of an already present mineral imbalance after initial 
therapy, with production of a different imbalance with further therapy. I f such be 
the case, it would appear advisable to control the duration and frequency of chelation 
therapy in this disorder by measuring the effect of therapy on correction of the 
tryptophan abnormality, rather than the present empiric methods. 
Pyridoxine also seems to have a definite place in the therapeutic program, not 
only during chelation, but indefinitely in view of the effect of the vitamin on 
tryptophan metabolism. Historically, it is interesting to note the combined use of 
chelation and pyridoxine by Leckert et al." and Davis and Moe,'' chelation used 
"to reduce calcinosis" and pyridoxine for its anti-emetic action or to prevent skin 
lesions resembling vitamin B6 deficiency. 
ScherbeP has reported on the clinical use of serotonin antagonists. He noted 
that local injection resulted in immediate decrease of pain and stiffness. In his hands, 
oral administration was most effective in Raynaud's phenomenon due to systemic 
sclerosis, and he noted slow, progressive loosening of connective tissue, softening of 
skin, healing of ulcers and decrease in calcification. The local use of amine oxidase 
inhibitors has been reported, also by Scherbel"" to hasten the healing of ischemic or 
ulcerative lesions of Raynaud's phenomenon. The decrease in local serotonin activity 
caused by these two agents makes their use reasonable when applied to the proposed 
pathogenesis. 
Zarafonetis' has suggested the possible role of serotonin in the etiology of 
Raynaud's phenomenon and suggests that potassium para-aminobenzoate may exert 
its effect by increasing tissue oxygen uptake, thus increasing the activity of oxygen 
dependent mono-amine oxidase or other enzymes. 
It is readily apparent that steroids, other than their non-specific anti-inflammatory 
action, play no role in the concept presented. Whether this explains their lack of 
clinical effect remains to be seen. 
Should the tryptophan abnormality prove to be related to etiology by elevation 
of serotonin levels, the combination of chelation, serotonin antagonists and amine 
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oxidase inhibitors might be more effective than any one alone. Further definition 
of the abnormality and clinical trails of the combination are indicated. 
L-Tryptophan Loading Test as cud to Differential Diagnosis 
The lack of response to steroids and possible contraindication to their use in 
systemic sclerosis make the exact diagnosis of this condition important. In those 
situations in which the differential diagnosis between systemic sclerosis and the 
other collagen diseases, particularly polymyositis and lupus erythematosus as noted 
by Winklemann,is very difficult, the abnormality of tryptophan excretion products, 
if specific for systemic sclerosis, would be helpful in diagnosis. 
In a large series of patients with polymyositis, we" have encountered a fairly 
well defined syndrome (interstitial myositis), which seems to be more closely related 
to systemic sclerosis than to polymyositis. Study of the tryptophan metabolism in 
this condition may prove to be helpful in further clarification. 
Price et al." have studied a few patients with muscular dystrophy and various 
neurological disorders and found normal tryptophan metabolite excretion. Thirteen 
of eighteen patients with porphyria and six of eight with various psychoses were 
found to be abnormal. Price™ also found normal metabolic patterns in a small 
number of patients with diabetes, psoriasis and atopic dermatitis. Johnson" found 
three patients with sarcoidosis to have normal tryptophan excretion patterns, but 
despite this both he and Rukavina and Dahlen" noted improvement in their patients 
after chelation. This is probably related to increased serum calcium, magnesium and 
other ions present in this disorder and their affect on some other enzyme system. 
The abnormality noted by Price" in some patients with lupus erythematosus is 
disturbing in respect to the potential value of this test in diagnosis. Pregnancy, cancer 
(except that associated with polymyositis) and porphyria should cause no problem 
in this respect. 
Obviously, extensive investigation of the significance of the tryptophan abnormality 
and its rate of occurrence in the diseases of the "collagen group" will be necessary 
before any use may be made of this abnormality in differential diagnosis. 
SUMMARY 
1. Fourteen cases of systemic sclerosis have been treated with disodium EDTA and/or 
pyridoxine in the past three years. Improvement in symptoms and objective im-
provement in sclerosis of the skin and other organs has been sufficiently constant 
to warrant further trials of this agent in therapy. 
2. A brief summary of the literature is included to indicate the observed abnormalities 
in tryptophan metabolite excretion and to relate this to the possible abnormality 
in tryptophan metabolism. 
3. The role of pyridoxine in tryptophan metabolism is reviewed. 
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4. Evidence to support the dependence of pyridoxine utilization on a normal heavy 
metal balance is stated. 
5. The role of chelation in correction of the tryptophan-niacin pathway abnormality 
by its affect on the heavy metal-pyridoxine relationship is reviewed. 
6. Present evidence and experimental work suggesting the role of serotonin in the 
pathogenesis of systemic sclerosis is reviewed, and a possible relationship between 
disordered tryptophan-niacin metabolism and elevated serotonin production is 
suggested. 
7. The role of presently useful therapeutic agents is related to their possible place 
in correction of abnormalities in tryptophan metabolism. 
8. The use of the L-tryptophan loading test in differential diagnosis is suggested. 
The authors are indebted to Doctor E. W. Whitehouse for permission to include patient, 
A.P., and to Doctor R. W. Hunter for permission to include patient, C.E., in this study. 
The UML-491 used in this study was supplied through the courtesy of Doctor Sidney 
Girapel. Sandoz Pharmaceuticals, Sandoz, Inc., Hanover, New Jersey. 
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